Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2021 Sep 13;73(11):1672–1677. doi: 10.1002/acr.24392

Figure 1.

Figure 1.

Proportion of youth with systemic lupus erythematosus (SLE) with an immunomodulatory medication prescription filled within the first year after diagnosis. The graph shows the percentage of youth with at least 1 prescription filled for an immunomodulatory medication (hydroxychloroquine, oral immunosuppressants [IS]) or oral glucocorticoids within the first year after SLE diagnosis. Of 532 youth with SLE, 295 (55%), 324 (61%), and 366 (69%) filled a prescription for hydroxychloroquine at 3, 6, and 12 months, respectively. Only 83 (16%), 124 (23%), and 182 (34%) youth filled a prescription for oral immunosuppressants at 3, 6, and 12 months, respectively, while 280 (53%), 313 (59%), and 340 (64%) youth filled a prescription for any oral glucocorticoid within the respective time points.